Future Market Insights opines that the clinical GenAI safety monitoring market was valued at USD 450 million in 2025. Demand is expected to grow to USD 527 million in 2026 and USD 2,100 million by 2036. Hallucination and clinical risk monitoring are expected to lead with 29% share in 2026, and hospitals and IDNs are estimated to lead the care setting segment with 46% in 2026.